FX3-14522-68094
2 vaccinations
2 coded responses
23 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 535 / WI
- Registered
- 2021-03-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-11
Registered in v-safe
-
2021-03-11
Dose 1 — Pfizer-BioNTech
-
2021-03-11
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-03-13
-
2021-03-14
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness — Feeling: Fair · Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesFree text: Light headednessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-15
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-03-16
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2021-03-17
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-18
Health check-in — day 7, dose 1Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-25
- 2021-04-01
-
2021-04-08
Dose 2 — Pfizer-BioNTech
-
2021-04-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
- 2021-04-11
-
2021-04-12
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness, DiarrheaAdult check-in
-
2021-04-13
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Fever · Chills, Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-04-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-04-15
Health check-in — day 7, dose 2Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-22
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-07-08
- 2021-10-07
-
2022-04-08
Survey response — 12 months, dose 2MedDRA: Benign hydatidiform mole, Medical procedure, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Molar pregnancy · Healthcare visit (other): Outpatient ProcedureMedDRA releases: 2024-11 · check-in free text available
-
2022-04-08
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-11 | Pfizer-BioNTech | |
| 2 | 2021-04-08 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-08 | Unsuccessful |
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Light headedness
Release 11 — 12 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical procedure | · | · | ✓ |
| HCVO | Office visit | · | · | ✓ |
| SD | Benign hydatidiform mole | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release